141 related articles for article (PubMed ID: 38775250)
21. Advanced digestive neuroendocrine tumors: metastatic pattern is an independent factor affecting clinical outcome.
Panzuto F; Merola E; Rinzivillo M; Partelli S; Campana D; Iannicelli E; Pilozzi E; Mercantini P; Rossi M; Capurso G; Scarpa A; Cascinu S; Tomassetti P; Falconi M; Delle Fave G
Pancreas; 2014 Mar; 43(2):212-8. PubMed ID: 24518498
[TBL] [Abstract][Full Text] [Related]
22. Triceps skinfold-albumin index significantly predicts the prognosis of cancer cachexia: A multicentre cohort study.
Yin L; Cui J; Lin X; Li L; Li N; Fan Y; Zhang L; Liu J; Chong F; Lu Z; Wang C; Liang T; Liu X; Deng L; Yang M; Yu J; Wang X; Cong M; Li Z; Weng M; Yao Q; Jia P; Guo Z; Li W; Song C; Shi H; Xu H
J Cachexia Sarcopenia Muscle; 2023 Feb; 14(1):517-533. PubMed ID: 36567070
[TBL] [Abstract][Full Text] [Related]
23. Cancer cachexia, sarcopenia and biochemical markers in patients with advanced non-small cell lung cancer-chemotherapy toxicity and prognostic value.
Srdic D; Plestina S; Sverko-Peternac A; Nikolac N; Simundic AM; Samarzija M
Support Care Cancer; 2016 Nov; 24(11):4495-502. PubMed ID: 27236439
[TBL] [Abstract][Full Text] [Related]
24. The prognosis of incurable cachectic cancer patients on home parenteral nutrition: a multi-centre observational study with prospective follow-up of 414 patients.
Bozzetti F; Santarpia L; Pironi L; Thul P; Klek S; Gavazzi C; Tinivella M; Joly F; Jonkers C; Baxter J; Gramlich L; Chicharro L; Staun M; Van Gossum A; Lo Vullo S; Mariani L
Ann Oncol; 2014 Feb; 25(2):487-93. PubMed ID: 24406425
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of immunotherapy in elderly patients with non-small cell lung cancer.
Galli G; De Toma A; Pagani F; Randon G; Trevisan B; Prelaj A; Ferrara R; Proto C; Signorelli D; Ganzinelli M; Zilembo N; de Braud F; Garassino MC; Lo Russo G
Lung Cancer; 2019 Nov; 137():38-42. PubMed ID: 31526910
[TBL] [Abstract][Full Text] [Related]
26. Survival and biomarkers for cachexia in non-small cell lung cancer receiving immune checkpoint inhibitors.
Murata D; Azuma K; Matsuo N; Murotani K; Matama G; Kawahara A; Sasada T; Tokito T; Hoshino T
Cancer Med; 2023 Oct; 12(19):19471-19479. PubMed ID: 37712645
[TBL] [Abstract][Full Text] [Related]
27. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
[No Abstract] [Full Text] [Related]
28. The Impact of Poorly Differentiated Histology on Immunotherapy in Advanced Gastrointestinal Cancers.
Draper A; Jung EH; Cao Y; Atallah RP; Switchenko J; Kane S; Guadagno J; Jones AT; Brutcher E; Alese OB
Oncology; 2023; 101(4):213-223. PubMed ID: 36626879
[TBL] [Abstract][Full Text] [Related]
29. Association of systemic inflammation with survival in patients with cancer cachexia: results from a multicentre cohort study.
Zhang Q; Song MM; Zhang X; Ding JS; Ruan GT; Zhang XW; Liu T; Yang M; Ge YZ; Tang M; Li XR; Qian L; Song CH; Xu HX; Shi HP
J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):1466-1476. PubMed ID: 34337882
[TBL] [Abstract][Full Text] [Related]
30. Impact of cancer cachexia on the therapeutic outcome of combined chemoimmunotherapy in patients with non-small cell lung cancer: a retrospective study.
Morimoto K; Uchino J; Yokoi T; Kijima T; Goto Y; Nakao A; Hibino M; Takeda T; Yamaguchi H; Takumi C; Takeshita M; Chihara Y; Yamada T; Hiranuma O; Morimoto Y; Iwasaku M; Kaneko Y; Yamada T; Takayama K
Oncoimmunology; 2021; 10(1):1950411. PubMed ID: 34290909
[TBL] [Abstract][Full Text] [Related]
31. Impact of cachexia on outcomes in aggressive lymphomas.
Karmali R; Alrifai T; Fughhi IAM; Ng R; Chukkapalli V; Shah P; Basu S; Nathan S; Szymanski-Grant K; Gordon LI; Venugopal P; Penedo FJ; Borgia JA
Ann Hematol; 2017 Jun; 96(6):951-956. PubMed ID: 28417157
[TBL] [Abstract][Full Text] [Related]
32. Characterization of outcomes in patients with advanced genitourinary malignancies treated with immune checkpoint inhibitors.
Ma VT; Su CT; Hu M; Taylor JMG; Daignault-Newton S; Kellezi O; Dahl MN; Shah MA; Erickson S; Lora J; Hamasha R; Ali A; Yancey S; Kiros L; Balicki HM; Winfield DC; Green MD; Alva AS
Urol Oncol; 2021 Jul; 39(7):437.e1-437.e9. PubMed ID: 33495117
[TBL] [Abstract][Full Text] [Related]
33. Cachexia staging score predicts survival in patients with cancer who receive palliative care.
Ueshima J; Maeda K; Shimizu A; Nagano A; Ishida Y; Takeuchi T; Nonogaki T; Matsuyama R; Yamanaka Y; Murotani K; Mori N
Nutrition; 2023 Feb; 106():111880. PubMed ID: 36436335
[TBL] [Abstract][Full Text] [Related]
34. Fecal Microbiota Transplantation from Overweight or Obese Donors in Cachectic Patients with Advanced Gastroesophageal Cancer: A Randomized, Double-blind, Placebo-Controlled, Phase II Study.
de Clercq NC; van den Ende T; Prodan A; Hemke R; Davids M; Pedersen HK; Nielsen HB; Groen AK; de Vos WM; van Laarhoven HWM; Nieuwdorp M
Clin Cancer Res; 2021 Jul; 27(13):3784-3792. PubMed ID: 33883174
[TBL] [Abstract][Full Text] [Related]
35. Early cancer cachexia phenotype predicts survival of advanced urothelial cancer patients treated with pembrolizumab.
Yamamoto S; Fukushima H; Fukuda S; Uehara S; Yasuda Y; Tanaka H; Yoshida S; Yokoyama M; Matsuoka Y; Fujii Y
Asia Pac J Clin Oncol; 2022 Aug; 18(4):410-418. PubMed ID: 34811871
[TBL] [Abstract][Full Text] [Related]
36. The applicability of a weight loss grading system in cancer cachexia: a longitudinal analysis.
Vagnildhaug OM; Blum D; Wilcock A; Fayers P; Strasser F; Baracos VE; Hjermstad MJ; Kaasa S; Laird B; Solheim TS;
J Cachexia Sarcopenia Muscle; 2017 Oct; 8(5):789-797. PubMed ID: 28627024
[TBL] [Abstract][Full Text] [Related]
37. Prognostic implication of erector spinae muscles in non-small-cell lung cancer patients treated with immuno-oncology combinatorial chemotherapy.
Araki T; Kitaguchi Y; Suzuki Y; Komatsu M; Sonehara K; Wada Y; Tateishi K; Hanaoka M
Thorac Cancer; 2021 Nov; 12(21):2857-2864. PubMed ID: 34599854
[TBL] [Abstract][Full Text] [Related]
38. [A multi-center retrospective study of perioperative chemotherapy for gastric cancer based on real-world data].
Ding XW; Zheng ZC; Zhao Q; Zhai G; Liang H; Wu X; Zhu ZG; Wang HJ; He QS; He XL; Du YA; Chen LC; Hua YW; Huang CM; Xue YW; Zhou Y; Zhou YB; Wu D; Fang XD; Dai YG; Zhang HW; Cao JQ; Li LP; Chai J; Tao KX; Li GL; Jie ZG; Ge J; Xu ZF; Zhang WB; Li QY; Zhao P; Ma ZQ; Yan ZL; Zheng GL; Yan Y; Tang XL; Zhou X
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 May; 24(5):403-412. PubMed ID: 34000769
[No Abstract] [Full Text] [Related]
39. Cancer Cachexia Reduces the Efficacy of Nivolumab Treatment in Patients With Advanced Gastric Cancer.
Fujii H; Makiyama A; Iihara H; Okumura N; Yamamoto S; Imai T; Arakawa S; Kobayashi R; Tanaka Y; Yoshida K; Suzuki A
Anticancer Res; 2020 Dec; 40(12):7067-7075. PubMed ID: 33288604
[TBL] [Abstract][Full Text] [Related]
40. Geriatric Nutrition Risk Index: Prognostic factor related to inflammation in elderly patients with cancer cachexia.
Ruan GT; Zhang Q; Zhang X; Tang M; Song MM; Zhang XW; Li XR; Zhang KP; Ge YZ; Yang M; Li QQ; Chen YB; Yu KY; Cong MH; Li W; Wang KH; Shi HP
J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):1969-1982. PubMed ID: 34585849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
